link to homepage

Institute of Neuroscience and Medicine

Navigation and service

Non-standard radionuclides

The efficient production of radionuclides in high amounts of radio activity, with high chemical and radionuclidic purity, is an essential prerequisite for radiopharmaceutical research and development.

Radionuclide development addresses production of suitable radioactive isotopes at a cyclotron, the investigation of their properties and the development of efficient radiochemical separation procedures in order to make those radionuclides available for medical application.

Besides established radionuclides, of which some are already routinely used for medical diagnosis and therapy for quite some time, further novel radionuclides are drawing interest for special applications in recent years.  

Radionuclide research and production comprises both fundamental research as well as practice oriented work. It ranges from determination of nuclear reaction data via technical aspects of practical radionuclide production to quality assurance. Important key aspects addressed in the working group are:

  • Targets and target stations for irradiation
  • Nuclear reaction and decay data measurements
  • Sample preparation
  • Radiochemical separation procedures
  • Quality control

The INM-5 has a long tradition in radionuclide research with a very good reputation for development of radioisotopes for medical diagnosis and therapy as well as for measurement of nuclear data for radionuclide production. Due to collaborations and networking with other institutions, like the Institute of Nuclear Physics (IKP-4), additional research possibilities can be created. At the Institute pioneer work has been done in the field of development and production of important PET- and SPECT-nucludes like 18F, 64Cu 123I and 124I.

Additional Information

Group Leader

Dr. Ingo Spahn

Gebäude: 15.19, Raum: 3022
Tel.:  +49-2461-61-4450